Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


Oliena Studio

Stroke and language recovery: 9000+ videos

EspañolItalianoSarduEnglish | PDF+


  Bladder Cancer

  Free Subscription


14.10.2019

1 Biochem Cell Biol
1 BJU Int
1 Bull Cancer
1 Cancer Biomark
1 Cancer Radiother
1 Cancers (Basel)
1 Clin Genitourin Cancer
1 Environ Toxicol
1 Int J Biol Sci
2 Int J Cancer
1 Int J Urol
1 J Cancer Res Clin Oncol
1 J Clin Invest
1 Mol Biol Rep
1 Nutr Cancer
1 Pan Afr Med J
3 Urol Oncol


  Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    Biochem Cell Biol

  1. LI G, Sun L, Mu Z, Liu S, et al
    MicroRNA-1298-5p inhibits cell proliferation and invasion of bladder cancer via downregulating connexin 43.
    Biochem Cell Biol. 2019 Oct 10. doi: 10.1139/bcb-2019-0137.
    PubMed     Text format     Abstract available


    BJU Int

  2. TAYLOR J, Becher E, Steinberg GD
    Update on the Guideline of Guidelines: Non-Muscle Invasive Bladder Cancer.
    BJU Int. 2019 Oct 9. doi: 10.1111/bju.14915.
    PubMed     Text format     Abstract available


    Bull Cancer

  3. OUEDRAOGO S, Traore MT, Kambire JL, Ouedraogo S, et al
    [Primary urological cancers in a context of limited resources: Epidemiology and treatment].
    Bull Cancer. 2019;106:868-874.
    PubMed     Text format     Abstract available


    Cancer Biomark

  4. LIU A, Xue Y, Liu F, Tan H, et al
    Prognostic value of the combined expression of tumor-associated trypsin inhibitor (TATI) and p53 in patients with bladder cancer undergoing radical cystectomy.
    Cancer Biomark. 2019 Sep 27. pii: CBM182143. doi: 10.3233/CBM-182143.
    PubMed     Text format     Abstract available


    Cancer Radiother

  5. BRIENS A, Castelli J, Barateau A, Jaksic N, et al
    [Adaptive radiotherapy: Strategies and benefits depending on tumor localization].
    Cancer Radiother. 2019;23.
    PubMed     Text format     Abstract available


    Cancers (Basel)

  6. PARK C, Cha HJ, Choi EO, Lee H, et al
    Isorhamnetin Induces Cell Cycle Arrest and Apoptosis Via Reactive Oxygen Species-Mediated AMP-Activated Protein Kinase Signaling Pathway Activation in Human Bladder Cancer Cells.
    Cancers (Basel). 2019;11.
    PubMed     Text format     Abstract available


    Clin Genitourin Cancer

  7. GRONOSTAJ K, Czech AK, Fronczek J, Drobniak A, et al
    The Prognostic Value of Tumor Regression Grades Combined With TNM Classification in Patients With Muscle-Invasive Bladder Cancer Who Underwent Neoadjuvant Chemotherapy Followed by Radical Cystectomy.
    Clin Genitourin Cancer. 2019 Sep 12. pii: S1558-7673(19)30272.
    PubMed     Text format     Abstract available


    Environ Toxicol

  8. TSAI TF, Chen PC, Lin YC, Chou KY, et al
    Benzyl isothiocyanate promotes miR-99a expression through ERK/AP-1-dependent pathway in bladder cancer cells.
    Environ Toxicol. 2019 Oct 6. doi: 10.1002/tox.22841.
    PubMed     Text format     Abstract available


    Int J Biol Sci

  9. ZHOU Q, Chen S, Lu M, Luo Y, et al
    EFEMP2 suppresses epithelial-mesenchymal transition via Wnt/beta-catenin signaling pathway in human bladder cancer.
    Int J Biol Sci. 2019;15:2139-2155.
    PubMed     Text format     Abstract available


    Int J Cancer

  10. ZENG H, Liu Z, Wang Z, Zhou Q, et al
    Intratumoral IL22-producing cells define immunoevasive subtype muscle-invasive bladder cancer with poor prognosis and superior nivolumab responses.
    Int J Cancer. 2019 Oct 4. doi: 10.1002/ijc.32715.
    PubMed     Text format     Abstract available

  11. JACK S, Madhivanan K, Ramadesikan S, Subramanian S, et al
    A Novel, Safe, Fast, Efficient Treatment for Her2-positive and Negative Bladder Cancer Utilizing an EGF-Anthrax Toxin Chimera.
    Int J Cancer. 2019 Oct 4. doi: 10.1002/ijc.32719.
    PubMed     Text format     Abstract available


    Int J Urol

  12. MATSUMOTO H
    Editorial Comment from Dr Matsumoto to Intraoperative hypotension caused by oral administration of 5-aminolevulinic acid for photodynamic diagnosis in patients with bladder cancer.
    Int J Urol. 2019 Oct 6. doi: 10.1111/iju.14131.
    PubMed     Text format    


    J Cancer Res Clin Oncol

  13. PAPADIMITRIOU MA, Avgeris M, Levis PK, Tokas T, et al
    DeltaNp63 transcript loss in bladder cancer constitutes an independent molecular predictor of TaT1 patients post-treatment relapse and progression.
    J Cancer Res Clin Oncol. 2019 Oct 8. pii: 10.1007/s00432-019-03028.
    PubMed     Text format     Abstract available


    J Clin Invest

  14. CHEN C, Luo Y, He W, Zhao Y, et al
    Exosomal long noncoding RNA LNMAT2 promotes lymphatic metastasis in bladder cancer.
    J Clin Invest. 2019 Oct 8. pii: 130892. doi: 10.1172/JCI130892.
    PubMed     Text format     Abstract available


    Mol Biol Rep

  15. ROUDAFSHANI Z, Jazayeri MH, Mahmoudi AR, Nedaeinia R, et al
    Evaluation of the frequency of CD5(+) B cells as natural immunoglobulin M producers and circulating soluble CD5 in patients with bladder cancer.
    Mol Biol Rep. 2019 Oct 5. pii: 10.1007/s11033-019-05087.
    PubMed     Text format     Abstract available


    Nutr Cancer

  16. CHESTNUT C, Smelser W, Dum T, Bechtel M, et al
    Glycemic impact of a diet and lifestyle intervention on diabetics and prediabetics during treatment for non-muscle invasive bladder cancer.
    Nutr Cancer. 2019 Oct 7:1-6. doi: 10.1080/01635581.2019.1672761.
    PubMed     Text format     Abstract available


    Pan Afr Med J

  17. KASANGA TK, Ntanga DI, Musapoudi EM, Kapessa ND, et al
    [Recurrent invasive bladder urothelial carcinoma treated by cystectomy with substitutive ileal enterocystoplasty: case report].
    Pan Afr Med J. 2019;33:184.
    PubMed     Text format     Abstract available


    Urol Oncol

  18. CARRION A, Huguet J, Ribal MJ, Dominguez A, et al
    Comparison of standard vs. palliative management for bladder cancer in patients older than 85 years: multicenter study of 317 de novo tumors.
    Urol Oncol. 2019 Oct 2. pii: S1078-1439(19)30358.
    PubMed     Text format     Abstract available

  19. GENITSCH V, Kollar A, Vandekerkhove G, Blarer J, et al
    Morphologic and genomic characterization of urothelial to sarcomatoid transition in muscle-invasive bladder cancer.
    Urol Oncol. 2019 Oct 1. pii: S1078-1439(19)30376.
    PubMed     Text format     Abstract available

  20. BURGESS EF, Livasy C, Trufan S, Hartman A, et al
    High aurora kinase expression identifies patients with muscle-invasive bladder cancer who have poor survival after neoadjuvant chemotherapy.
    Urol Oncol. 2019 Oct 6. pii: S1078-1439(19)30360.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Bladder Cancer is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: